EP3880186
INTRALESIONAL ADMINISTRATION OF PD-1 INHIBITORS FOR TREATING SKIN CANCER
Status:
EP einkaleyfi í gildi á ÍslandiEP appl. date:
13.11.2019EP published:
3.4.2024EP application number:
19817846.9
EP translation filed:
28.5.2024Grant published:
15.6.2024EPO information:
European Patent Register
Max expiry date:
12.11.2039Expiry date:
12.11.2026Next due date:
30.11.2026
Title in English:
INTRALESIONAL ADMINISTRATION OF PD-1 INHIBITORS FOR TREATING SKIN CANCERLanguage of the patent:
English
Timeline
Today
13.11.2019EP application
3.4.2024EP Publication
28.5.2024Translation submitted
15.6.2024Registration published
12.11.2026Expires
Owner
Name:
Regeneron Pharmaceuticals, Inc.Address:
777 Old Saw Mill River Road, Tarrytown, NY 10591-6706, US
Inventor
Name:
FURY, Matthew G.Address:
Tarrytown, NY 10591, US
Name:
LOWY, IsraelAddress:
Tarrytown, NY 10591, US
Agent
Name:
Zacco Denmark A/SAddress:
Arne Jacobsens Allé 15, DK
Priority
Number:
201862767218 PDate:
14.11.2018Country:
US
Classification
Categories:
A61K 31/00, A61K 39/00, A61K 39/395, C07K 16/28, A61K 45/06, A61K 9/00, A61P 35/00
Annual fees
Number
Paid
Expires
Payer
Number: 6
Paid: 25.10.2024
Expires: 12.11.2025
Payer: Árnason Faktor ehf.
Number: 7
Paid: 11.11.2025
Expires: 12.11.2026
Payer: Árnason Faktor ehf.